142 related articles for article (PubMed ID: 8664123)
21. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
22. Comparative prognostic value of Cathepsin D and urokinase plasminogen activator, detected by immunohistochemistry, in primary breast carcinoma.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G
Anticancer Res; 1996; 16(2):1011-8. PubMed ID: 8687092
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of cathepsin D in breast cancer: comparison of immunohistochemical and immunoradiometric detection methods.
Göhring UJ; Scharl A; Thelen U; Ahr A; Crombach G; Titius BR
J Clin Pathol; 1996 Jan; 49(1):57-64. PubMed ID: 8666688
[TBL] [Abstract][Full Text] [Related]
24. Clinical prognostic factors and expression of cathepsin D in endometrioid adenocarcinoma.
Dvalishvili I; Charkviani L; Charkviani T; Turashvili G; Burkadze G
Georgian Med News; 2005 Sep; (126):27-31. PubMed ID: 16234588
[TBL] [Abstract][Full Text] [Related]
25. The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.
Shin IY; Sung NY; Lee YS; Kwon TS; Si Y; Lee YS; Oh ST; Lee IK
Gut Liver; 2014 Jan; 8(1):13-23. PubMed ID: 24516696
[TBL] [Abstract][Full Text] [Related]
26. Endometrial adenocarcinoma of endometrioid subtype with squamous differentiation: an immunohistochemical study of MIB-1 (ki-67 paraffin), cathepsin D, and C-erbB-2 protein (p185).
Nielsen AL; Nyholm HC
Int J Gynecol Pathol; 1995 Jul; 14(3):230-4. PubMed ID: 8600074
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of cathepsin-D in patients with breast cancer.
Winstanley JH; Leinster SJ; Cooke TG; Westley BR; Platt-Higgins AM; Rudland PS
Br J Cancer; 1993 Apr; 67(4):767-72. PubMed ID: 8471433
[TBL] [Abstract][Full Text] [Related]
28. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
[TBL] [Abstract][Full Text] [Related]
29. Influence of cathepsin D expression in lung adenocarcinoma on prognosis: possible importance of its expression in tumor cells and stromal cells, and its intracellular polarization in tumor cells.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Kasugai T; Ishiguro S
J Surg Oncol; 1997 May; 65(1):10-9. PubMed ID: 9179261
[TBL] [Abstract][Full Text] [Related]
30. [Value of immunohistochemical determination of receptors, tissue proteases, tumor suppressor proteins and proliferation markers as prognostic indicators in primary breast carcinoma].
Göhring UJ; Scharl A; Ahr A
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):177-83. PubMed ID: 8682282
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cathepsin D as a prognostic factor in breast cancer.
Ravdin PM
Breast Cancer Res Treat; 1993; 24(3):219-26. PubMed ID: 8435477
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin D and prognosis in breast cancer.
Tandon AK; Clark GM; Chamness GC; Chirgwin JM; McGuire WL
N Engl J Med; 1990 Feb; 322(5):297-302. PubMed ID: 2296271
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin D: an independent prognostic factor for metastasis of breast cancer.
Spyratos F; Maudelonde T; Brouillet JP; Brunet M; Defrenne A; Andrieu C; Hacene K; Desplaces A; Rouëssé J; Rochefort H
Lancet; 1989 Nov; 2(8672):1115-8. PubMed ID: 2572846
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of cathepsin D expression and association with histomorphological subtypes in breast cancer.
Lösch A; Tempfer C; Kohlberger P; Joura EA; Denk M; Zajic B; Breitenecker G; Kainz C
Br J Cancer; 1998 Jul; 78(2):205-9. PubMed ID: 9683294
[TBL] [Abstract][Full Text] [Related]
35. Endometrial carcinoma expresses an increased cathepsin B/D ratio.
Bradley WH; Lima PH; Rodgers L; Blomquist CH; Downs LS
Gynecol Oncol; 2008 Jan; 108(1):84-9. PubMed ID: 17980407
[TBL] [Abstract][Full Text] [Related]
36. Changes in Chromatin Structure in Curettage Specimens Identifies High-Risk Patients in Endometrial Cancer.
Hveem TS; Njølstad TS; Nielsen B; Syvertsen RA; Nesheim JA; Kjæreng ML; Kildal W; Pradhan M; Marcickiewicz J; Tingulstad S; Staff AC; Haugland HK; Eraker R; Oddenes K; Rokne JA; Tjugum J; Lode MS; Amant F; Werner HM; Bjørge L; Albregtsen F; Liestøl K; Salvesen HB; Trovik J; Danielsen HE;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):61-67. PubMed ID: 27587790
[TBL] [Abstract][Full Text] [Related]
37. Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.
Nikolić-Vukosavljević D; Markićević M; Grujić-Adanja G; Petrović A; Kanjer K; Nesković-Konstantinović Z
Clin Exp Metastasis; 2005; 22(4):363-8. PubMed ID: 16170672
[TBL] [Abstract][Full Text] [Related]
38. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
[TBL] [Abstract][Full Text] [Related]
39. Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.
Leto G; Tumminello FM; Crescimanno M; Flandina C; Gebbia N
Clin Exp Metastasis; 2004; 21(2):91-106. PubMed ID: 15168727
[TBL] [Abstract][Full Text] [Related]
40. Significance of cathepsin-D expression in uterine tumours.
Scambia G; Benedetti Panici P; Ferrandina G; Distefano M; Romanini ME; Sica G; Mancuso S
Eur J Cancer; 1995; 31A(9):1449-54. PubMed ID: 7577070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
